Global Advanced Therapy Based on Gene Market Research Report 2024, Forecast to 2032
Report Overview
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Advanced Therapy Based on Gene market size was estimated at USD 9063 million in 2023 and is projected to reach USD 47469.23 million by 2032, exhibiting a CAGR of 20.20% during the forecast period.
North America Advanced Therapy Based on Gene market size was estimated at USD 3250.13 million in 2023, at a CAGR of 17.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Advanced Therapy Based on Gene market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Advanced Therapy Based on Gene Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Advanced Therapy Based on Gene market in any manner.
Global Advanced Therapy Based on Gene Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral
Non-viral
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Advanced Therapy Based on Gene Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Advanced Therapy Based on Gene, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Advanced Therapy Based on Gene is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
The global Advanced Therapy Based on Gene market size was estimated at USD 9063 million in 2023 and is projected to reach USD 47469.23 million by 2032, exhibiting a CAGR of 20.20% during the forecast period.
North America Advanced Therapy Based on Gene market size was estimated at USD 3250.13 million in 2023, at a CAGR of 17.31% during the forecast period of 2024 through 2032.
This report provides a deep insight into the global Advanced Therapy Based on Gene market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Advanced Therapy Based on Gene Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Advanced Therapy Based on Gene market in any manner.
Global Advanced Therapy Based on Gene Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Market Segmentation (by Type)
Viral
Non-viral
Market Segmentation (by Application)
Neurological Diseases
Cancer
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Advanced Therapy Based on Gene Market
- Overview of the regional outlook of the Advanced Therapy Based on Gene Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Advanced Therapy Based on Gene Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Advanced Therapy Based on Gene, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Advanced Therapy Based on Gene
1.2 Key Market Segments
1.2.1 Advanced Therapy Based on Gene Segment by Type
1.2.2 Advanced Therapy Based on Gene Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADVANCED THERAPY BASED ON GENE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Advanced Therapy Based on Gene Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Advanced Therapy Based on Gene Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADVANCED THERAPY BASED ON GENE MARKET COMPETITIVE LANDSCAPE
3.1 Global Advanced Therapy Based on Gene Sales by Manufacturers (2019-2024)
3.2 Global Advanced Therapy Based on Gene Revenue Market Share by Manufacturers (2019-2024)
3.3 Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Advanced Therapy Based on Gene Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Advanced Therapy Based on Gene Sales Sites, Area Served, Product Type
3.6 Advanced Therapy Based on Gene Market Competitive Situation and Trends
3.6.1 Advanced Therapy Based on Gene Market Concentration Rate
3.6.2 Global 5 and 10 Largest Advanced Therapy Based on Gene Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADVANCED THERAPY BASED ON GENE INDUSTRY CHAIN ANALYSIS
4.1 Advanced Therapy Based on Gene Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADVANCED THERAPY BASED ON GENE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ADVANCED THERAPY BASED ON GENE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Advanced Therapy Based on Gene Sales Market Share by Type (2019-2024)
6.3 Global Advanced Therapy Based on Gene Market Size Market Share by Type (2019-2024)
6.4 Global Advanced Therapy Based on Gene Price by Type (2019-2024)
7 ADVANCED THERAPY BASED ON GENE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Advanced Therapy Based on Gene Market Sales by Application (2019-2024)
7.3 Global Advanced Therapy Based on Gene Market Size (M USD) by Application (2019-2024)
7.4 Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
8 ADVANCED THERAPY BASED ON GENE MARKET CONSUMPTION BY REGION
8.1 Global Advanced Therapy Based on Gene Sales by Region
8.1.1 Global Advanced Therapy Based on Gene Sales by Region
8.1.2 Global Advanced Therapy Based on Gene Sales Market Share by Region
8.2 North America
8.2.1 North America Advanced Therapy Based on Gene Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Advanced Therapy Based on Gene Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Advanced Therapy Based on Gene Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Advanced Therapy Based on Gene Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Advanced Therapy Based on Gene Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ADVANCED THERAPY BASED ON GENE MARKET PRODUCTION BY REGION
9.1 Global Production of Advanced Therapy Based on Gene by Region (2019-2024)
9.2 Global Advanced Therapy Based on Gene Revenue Market Share by Region (2019-2024)
9.3 Global Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Advanced Therapy Based on Gene Production
9.4.1 North America Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.4.2 North America Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Advanced Therapy Based on Gene Production
9.5.1 Europe Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.5.2 Europe Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Advanced Therapy Based on Gene Production (2019-2024)
9.6.1 Japan Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.6.2 Japan Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Advanced Therapy Based on Gene Production (2019-2024)
9.7.1 China Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.7.2 China Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Advanced Therapy Based on Gene Basic Information
10.1.2 Biogen Advanced Therapy Based on Gene Product Overview
10.1.3 Biogen Advanced Therapy Based on Gene Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen Advanced Therapy Based on Gene SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Advanced Therapy Based on Gene Basic Information
10.2.2 Novartis Advanced Therapy Based on Gene Product Overview
10.2.3 Novartis Advanced Therapy Based on Gene Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis Advanced Therapy Based on Gene SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Advanced Therapy Based on Gene Basic Information
10.3.2 Gilead Sciences Advanced Therapy Based on Gene Product Overview
10.3.3 Gilead Sciences Advanced Therapy Based on Gene Product Market Performance
10.3.4 Gilead Sciences Advanced Therapy Based on Gene SWOT Analysis
10.3.5 Gilead Sciences Business Overview
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Advanced Therapy Based on Gene Basic Information
10.4.2 Sarepta Therapeutics Advanced Therapy Based on Gene Product Overview
10.4.3 Sarepta Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Basic Information
10.5.2 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Overview
10.5.3 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Advanced Therapy Based on Gene Basic Information
10.6.2 Amgen Advanced Therapy Based on Gene Product Overview
10.6.3 Amgen Advanced Therapy Based on Gene Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Advanced Therapy Based on Gene Basic Information
10.7.2 Spark Therapeutics Advanced Therapy Based on Gene Product Overview
10.7.3 Spark Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Advanced Therapy Based on Gene Basic Information
10.8.2 Akcea Therapeutics Advanced Therapy Based on Gene Product Overview
10.8.3 Akcea Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 Sunway Biotech
10.9.1 Sunway Biotech Advanced Therapy Based on Gene Basic Information
10.9.2 Sunway Biotech Advanced Therapy Based on Gene Product Overview
10.9.3 Sunway Biotech Advanced Therapy Based on Gene Product Market Performance
10.9.4 Sunway Biotech Business Overview
10.9.5 Sunway Biotech Recent Developments
10.10 SIBIONO
10.10.1 SIBIONO Advanced Therapy Based on Gene Basic Information
10.10.2 SIBIONO Advanced Therapy Based on Gene Product Overview
10.10.3 SIBIONO Advanced Therapy Based on Gene Product Market Performance
10.10.4 SIBIONO Business Overview
10.10.5 SIBIONO Recent Developments
10.11 AnGes
10.11.1 AnGes Advanced Therapy Based on Gene Basic Information
10.11.2 AnGes Advanced Therapy Based on Gene Product Overview
10.11.3 AnGes Advanced Therapy Based on Gene Product Market Performance
10.11.4 AnGes Business Overview
10.11.5 AnGes Recent Developments
10.12 Orchard Therapeutics
10.12.1 Orchard Therapeutics Advanced Therapy Based on Gene Basic Information
10.12.2 Orchard Therapeutics Advanced Therapy Based on Gene Product Overview
10.12.3 Orchard Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.12.4 Orchard Therapeutics Business Overview
10.12.5 Orchard Therapeutics Recent Developments
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Advanced Therapy Based on Gene Basic Information
10.13.2 Human Stem Cells Institute Advanced Therapy Based on Gene Product Overview
10.13.3 Human Stem Cells Institute Advanced Therapy Based on Gene Product Market Performance
10.13.4 Human Stem Cells Institute Business Overview
10.13.5 Human Stem Cells Institute Recent Developments
11 ADVANCED THERAPY BASED ON GENE MARKET FORECAST BY REGION
11.1 Global Advanced Therapy Based on Gene Market Size Forecast
11.2 Global Advanced Therapy Based on Gene Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Advanced Therapy Based on Gene Market Size Forecast by Country
11.2.3 Asia Pacific Advanced Therapy Based on Gene Market Size Forecast by Region
11.2.4 South America Advanced Therapy Based on Gene Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Advanced Therapy Based on Gene by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Advanced Therapy Based on Gene Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Advanced Therapy Based on Gene by Type (2025-2032)
12.1.2 Global Advanced Therapy Based on Gene Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Advanced Therapy Based on Gene by Type (2025-2032)
12.2 Global Advanced Therapy Based on Gene Market Forecast by Application (2025-2032)
12.2.1 Global Advanced Therapy Based on Gene Sales (K Units) Forecast by Application
12.2.2 Global Advanced Therapy Based on Gene Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Advanced Therapy Based on Gene
1.2 Key Market Segments
1.2.1 Advanced Therapy Based on Gene Segment by Type
1.2.2 Advanced Therapy Based on Gene Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADVANCED THERAPY BASED ON GENE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Advanced Therapy Based on Gene Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Advanced Therapy Based on Gene Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADVANCED THERAPY BASED ON GENE MARKET COMPETITIVE LANDSCAPE
3.1 Global Advanced Therapy Based on Gene Sales by Manufacturers (2019-2024)
3.2 Global Advanced Therapy Based on Gene Revenue Market Share by Manufacturers (2019-2024)
3.3 Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Advanced Therapy Based on Gene Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Advanced Therapy Based on Gene Sales Sites, Area Served, Product Type
3.6 Advanced Therapy Based on Gene Market Competitive Situation and Trends
3.6.1 Advanced Therapy Based on Gene Market Concentration Rate
3.6.2 Global 5 and 10 Largest Advanced Therapy Based on Gene Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ADVANCED THERAPY BASED ON GENE INDUSTRY CHAIN ANALYSIS
4.1 Advanced Therapy Based on Gene Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADVANCED THERAPY BASED ON GENE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ADVANCED THERAPY BASED ON GENE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Advanced Therapy Based on Gene Sales Market Share by Type (2019-2024)
6.3 Global Advanced Therapy Based on Gene Market Size Market Share by Type (2019-2024)
6.4 Global Advanced Therapy Based on Gene Price by Type (2019-2024)
7 ADVANCED THERAPY BASED ON GENE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Advanced Therapy Based on Gene Market Sales by Application (2019-2024)
7.3 Global Advanced Therapy Based on Gene Market Size (M USD) by Application (2019-2024)
7.4 Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
8 ADVANCED THERAPY BASED ON GENE MARKET CONSUMPTION BY REGION
8.1 Global Advanced Therapy Based on Gene Sales by Region
8.1.1 Global Advanced Therapy Based on Gene Sales by Region
8.1.2 Global Advanced Therapy Based on Gene Sales Market Share by Region
8.2 North America
8.2.1 North America Advanced Therapy Based on Gene Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Advanced Therapy Based on Gene Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Advanced Therapy Based on Gene Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Advanced Therapy Based on Gene Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Advanced Therapy Based on Gene Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 ADVANCED THERAPY BASED ON GENE MARKET PRODUCTION BY REGION
9.1 Global Production of Advanced Therapy Based on Gene by Region (2019-2024)
9.2 Global Advanced Therapy Based on Gene Revenue Market Share by Region (2019-2024)
9.3 Global Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.4 North America Advanced Therapy Based on Gene Production
9.4.1 North America Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.4.2 North America Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.5 Europe Advanced Therapy Based on Gene Production
9.5.1 Europe Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.5.2 Europe Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.6 Japan Advanced Therapy Based on Gene Production (2019-2024)
9.6.1 Japan Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.6.2 Japan Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
9.7 China Advanced Therapy Based on Gene Production (2019-2024)
9.7.1 China Advanced Therapy Based on Gene Production Growth Rate (2019-2024)
9.7.2 China Advanced Therapy Based on Gene Production, Revenue, Price and Gross Margin (2019-2024)
10 KEY COMPANIES PROFILE
10.1 Biogen
10.1.1 Biogen Advanced Therapy Based on Gene Basic Information
10.1.2 Biogen Advanced Therapy Based on Gene Product Overview
10.1.3 Biogen Advanced Therapy Based on Gene Product Market Performance
10.1.4 Biogen Business Overview
10.1.5 Biogen Advanced Therapy Based on Gene SWOT Analysis
10.1.6 Biogen Recent Developments
10.2 Novartis
10.2.1 Novartis Advanced Therapy Based on Gene Basic Information
10.2.2 Novartis Advanced Therapy Based on Gene Product Overview
10.2.3 Novartis Advanced Therapy Based on Gene Product Market Performance
10.2.4 Novartis Business Overview
10.2.5 Novartis Advanced Therapy Based on Gene SWOT Analysis
10.2.6 Novartis Recent Developments
10.3 Gilead Sciences
10.3.1 Gilead Sciences Advanced Therapy Based on Gene Basic Information
10.3.2 Gilead Sciences Advanced Therapy Based on Gene Product Overview
10.3.3 Gilead Sciences Advanced Therapy Based on Gene Product Market Performance
10.3.4 Gilead Sciences Advanced Therapy Based on Gene SWOT Analysis
10.3.5 Gilead Sciences Business Overview
10.3.6 Gilead Sciences Recent Developments
10.4 Sarepta Therapeutics
10.4.1 Sarepta Therapeutics Advanced Therapy Based on Gene Basic Information
10.4.2 Sarepta Therapeutics Advanced Therapy Based on Gene Product Overview
10.4.3 Sarepta Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.4.4 Sarepta Therapeutics Business Overview
10.4.5 Sarepta Therapeutics Recent Developments
10.5 Alnylam Pharmaceuticals
10.5.1 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Basic Information
10.5.2 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Overview
10.5.3 Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Market Performance
10.5.4 Alnylam Pharmaceuticals Business Overview
10.5.5 Alnylam Pharmaceuticals Recent Developments
10.6 Amgen
10.6.1 Amgen Advanced Therapy Based on Gene Basic Information
10.6.2 Amgen Advanced Therapy Based on Gene Product Overview
10.6.3 Amgen Advanced Therapy Based on Gene Product Market Performance
10.6.4 Amgen Business Overview
10.6.5 Amgen Recent Developments
10.7 Spark Therapeutics
10.7.1 Spark Therapeutics Advanced Therapy Based on Gene Basic Information
10.7.2 Spark Therapeutics Advanced Therapy Based on Gene Product Overview
10.7.3 Spark Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.7.4 Spark Therapeutics Business Overview
10.7.5 Spark Therapeutics Recent Developments
10.8 Akcea Therapeutics
10.8.1 Akcea Therapeutics Advanced Therapy Based on Gene Basic Information
10.8.2 Akcea Therapeutics Advanced Therapy Based on Gene Product Overview
10.8.3 Akcea Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.8.4 Akcea Therapeutics Business Overview
10.8.5 Akcea Therapeutics Recent Developments
10.9 Sunway Biotech
10.9.1 Sunway Biotech Advanced Therapy Based on Gene Basic Information
10.9.2 Sunway Biotech Advanced Therapy Based on Gene Product Overview
10.9.3 Sunway Biotech Advanced Therapy Based on Gene Product Market Performance
10.9.4 Sunway Biotech Business Overview
10.9.5 Sunway Biotech Recent Developments
10.10 SIBIONO
10.10.1 SIBIONO Advanced Therapy Based on Gene Basic Information
10.10.2 SIBIONO Advanced Therapy Based on Gene Product Overview
10.10.3 SIBIONO Advanced Therapy Based on Gene Product Market Performance
10.10.4 SIBIONO Business Overview
10.10.5 SIBIONO Recent Developments
10.11 AnGes
10.11.1 AnGes Advanced Therapy Based on Gene Basic Information
10.11.2 AnGes Advanced Therapy Based on Gene Product Overview
10.11.3 AnGes Advanced Therapy Based on Gene Product Market Performance
10.11.4 AnGes Business Overview
10.11.5 AnGes Recent Developments
10.12 Orchard Therapeutics
10.12.1 Orchard Therapeutics Advanced Therapy Based on Gene Basic Information
10.12.2 Orchard Therapeutics Advanced Therapy Based on Gene Product Overview
10.12.3 Orchard Therapeutics Advanced Therapy Based on Gene Product Market Performance
10.12.4 Orchard Therapeutics Business Overview
10.12.5 Orchard Therapeutics Recent Developments
10.13 Human Stem Cells Institute
10.13.1 Human Stem Cells Institute Advanced Therapy Based on Gene Basic Information
10.13.2 Human Stem Cells Institute Advanced Therapy Based on Gene Product Overview
10.13.3 Human Stem Cells Institute Advanced Therapy Based on Gene Product Market Performance
10.13.4 Human Stem Cells Institute Business Overview
10.13.5 Human Stem Cells Institute Recent Developments
11 ADVANCED THERAPY BASED ON GENE MARKET FORECAST BY REGION
11.1 Global Advanced Therapy Based on Gene Market Size Forecast
11.2 Global Advanced Therapy Based on Gene Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Advanced Therapy Based on Gene Market Size Forecast by Country
11.2.3 Asia Pacific Advanced Therapy Based on Gene Market Size Forecast by Region
11.2.4 South America Advanced Therapy Based on Gene Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Advanced Therapy Based on Gene by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2032)
12.1 Global Advanced Therapy Based on Gene Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Advanced Therapy Based on Gene by Type (2025-2032)
12.1.2 Global Advanced Therapy Based on Gene Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Advanced Therapy Based on Gene by Type (2025-2032)
12.2 Global Advanced Therapy Based on Gene Market Forecast by Application (2025-2032)
12.2.1 Global Advanced Therapy Based on Gene Sales (K Units) Forecast by Application
12.2.2 Global Advanced Therapy Based on Gene Market Size (M USD) Forecast by Application (2025-2032)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Advanced Therapy Based on Gene Market Size Comparison by Region (M USD)
Table 5. Global Advanced Therapy Based on Gene Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Advanced Therapy Based on Gene Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Advanced Therapy Based on Gene Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Advanced Therapy Based on Gene Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
Table 10. Global Market Advanced Therapy Based on Gene Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Advanced Therapy Based on Gene Sales Sites and Area Served
Table 12. Manufacturers Advanced Therapy Based on Gene Product Type
Table 13. Global Advanced Therapy Based on Gene Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Advanced Therapy Based on Gene
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Advanced Therapy Based on Gene Market Challenges
Table 22. Global Advanced Therapy Based on Gene Sales by Type (K Units)
Table 23. Global Advanced Therapy Based on Gene Market Size by Type (M USD)
Table 24. Global Advanced Therapy Based on Gene Sales (K Units) by Type (2019-2024)
Table 25. Global Advanced Therapy Based on Gene Sales Market Share by Type (2019-2024)
Table 26. Global Advanced Therapy Based on Gene Market Size (M USD) by Type (2019-2024)
Table 27. Global Advanced Therapy Based on Gene Market Size Share by Type (2019-2024)
Table 28. Global Advanced Therapy Based on Gene Price (USD/Unit) by Type (2019-2024)
Table 29. Global Advanced Therapy Based on Gene Sales (K Units) by Application
Table 30. Global Advanced Therapy Based on Gene Market Size by Application
Table 31. Global Advanced Therapy Based on Gene Sales by Application (2019-2024) & (K Units)
Table 32. Global Advanced Therapy Based on Gene Sales Market Share by Application (2019-2024)
Table 33. Global Advanced Therapy Based on Gene Sales by Application (2019-2024) & (M USD)
Table 34. Global Advanced Therapy Based on Gene Market Share by Application (2019-2024)
Table 35. Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
Table 36. Global Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 37. Global Advanced Therapy Based on Gene Sales Market Share by Region (2019-2024)
Table 38. North America Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 39. Europe Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 41. South America Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 43. Global Advanced Therapy Based on Gene Production (K Units) by Region (2019-2024)
Table 44. Global Advanced Therapy Based on Gene Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Advanced Therapy Based on Gene Revenue Market Share by Region (2019-2024)
Table 46. Global Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Biogen Advanced Therapy Based on Gene Basic Information
Table 52. Biogen Advanced Therapy Based on Gene Product Overview
Table 53. Biogen Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Biogen Business Overview
Table 55. Biogen Advanced Therapy Based on Gene SWOT Analysis
Table 56. Biogen Recent Developments
Table 57. Novartis Advanced Therapy Based on Gene Basic Information
Table 58. Novartis Advanced Therapy Based on Gene Product Overview
Table 59. Novartis Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Novartis Business Overview
Table 61. Novartis Advanced Therapy Based on Gene SWOT Analysis
Table 62. Novartis Recent Developments
Table 63. Gilead Sciences Advanced Therapy Based on Gene Basic Information
Table 64. Gilead Sciences Advanced Therapy Based on Gene Product Overview
Table 65. Gilead Sciences Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Gilead Sciences Advanced Therapy Based on Gene SWOT Analysis
Table 67. Gilead Sciences Business Overview
Table 68. Gilead Sciences Recent Developments
Table 69. Sarepta Therapeutics Advanced Therapy Based on Gene Basic Information
Table 70. Sarepta Therapeutics Advanced Therapy Based on Gene Product Overview
Table 71. Sarepta Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Sarepta Therapeutics Business Overview
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Basic Information
Table 75. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Overview
Table 76. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Alnylam Pharmaceuticals Business Overview
Table 78. Alnylam Pharmaceuticals Recent Developments
Table 79. Amgen Advanced Therapy Based on Gene Basic Information
Table 80. Amgen Advanced Therapy Based on Gene Product Overview
Table 81. Amgen Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Amgen Business Overview
Table 83. Amgen Recent Developments
Table 84. Spark Therapeutics Advanced Therapy Based on Gene Basic Information
Table 85. Spark Therapeutics Advanced Therapy Based on Gene Product Overview
Table 86. Spark Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Spark Therapeutics Business Overview
Table 88. Spark Therapeutics Recent Developments
Table 89. Akcea Therapeutics Advanced Therapy Based on Gene Basic Information
Table 90. Akcea Therapeutics Advanced Therapy Based on Gene Product Overview
Table 91. Akcea Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Akcea Therapeutics Business Overview
Table 93. Akcea Therapeutics Recent Developments
Table 94. Sunway Biotech Advanced Therapy Based on Gene Basic Information
Table 95. Sunway Biotech Advanced Therapy Based on Gene Product Overview
Table 96. Sunway Biotech Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sunway Biotech Business Overview
Table 98. Sunway Biotech Recent Developments
Table 99. SIBIONO Advanced Therapy Based on Gene Basic Information
Table 100. SIBIONO Advanced Therapy Based on Gene Product Overview
Table 101. SIBIONO Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. SIBIONO Business Overview
Table 103. SIBIONO Recent Developments
Table 104. AnGes Advanced Therapy Based on Gene Basic Information
Table 105. AnGes Advanced Therapy Based on Gene Product Overview
Table 106. AnGes Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. AnGes Business Overview
Table 108. AnGes Recent Developments
Table 109. Orchard Therapeutics Advanced Therapy Based on Gene Basic Information
Table 110. Orchard Therapeutics Advanced Therapy Based on Gene Product Overview
Table 111. Orchard Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Orchard Therapeutics Business Overview
Table 113. Orchard Therapeutics Recent Developments
Table 114. Human Stem Cells Institute Advanced Therapy Based on Gene Basic Information
Table 115. Human Stem Cells Institute Advanced Therapy Based on Gene Product Overview
Table 116. Human Stem Cells Institute Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Human Stem Cells Institute Business Overview
Table 118. Human Stem Cells Institute Recent Developments
Table 119. Global Advanced Therapy Based on Gene Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Advanced Therapy Based on Gene Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Advanced Therapy Based on Gene Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Advanced Therapy Based on Gene Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Advanced Therapy Based on Gene Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Advanced Therapy Based on Gene Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Advanced Therapy Based on Gene Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Advanced Therapy Based on Gene Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Advanced Therapy Based on Gene Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Advanced Therapy Based on Gene Market Size Forecast by Application (2025-2032) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Advanced Therapy Based on Gene Market Size Comparison by Region (M USD)
Table 5. Global Advanced Therapy Based on Gene Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Advanced Therapy Based on Gene Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Advanced Therapy Based on Gene Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Advanced Therapy Based on Gene Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Advanced Therapy Based on Gene as of 2022)
Table 10. Global Market Advanced Therapy Based on Gene Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Advanced Therapy Based on Gene Sales Sites and Area Served
Table 12. Manufacturers Advanced Therapy Based on Gene Product Type
Table 13. Global Advanced Therapy Based on Gene Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Advanced Therapy Based on Gene
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Advanced Therapy Based on Gene Market Challenges
Table 22. Global Advanced Therapy Based on Gene Sales by Type (K Units)
Table 23. Global Advanced Therapy Based on Gene Market Size by Type (M USD)
Table 24. Global Advanced Therapy Based on Gene Sales (K Units) by Type (2019-2024)
Table 25. Global Advanced Therapy Based on Gene Sales Market Share by Type (2019-2024)
Table 26. Global Advanced Therapy Based on Gene Market Size (M USD) by Type (2019-2024)
Table 27. Global Advanced Therapy Based on Gene Market Size Share by Type (2019-2024)
Table 28. Global Advanced Therapy Based on Gene Price (USD/Unit) by Type (2019-2024)
Table 29. Global Advanced Therapy Based on Gene Sales (K Units) by Application
Table 30. Global Advanced Therapy Based on Gene Market Size by Application
Table 31. Global Advanced Therapy Based on Gene Sales by Application (2019-2024) & (K Units)
Table 32. Global Advanced Therapy Based on Gene Sales Market Share by Application (2019-2024)
Table 33. Global Advanced Therapy Based on Gene Sales by Application (2019-2024) & (M USD)
Table 34. Global Advanced Therapy Based on Gene Market Share by Application (2019-2024)
Table 35. Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
Table 36. Global Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 37. Global Advanced Therapy Based on Gene Sales Market Share by Region (2019-2024)
Table 38. North America Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 39. Europe Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 41. South America Advanced Therapy Based on Gene Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Advanced Therapy Based on Gene Sales by Region (2019-2024) & (K Units)
Table 43. Global Advanced Therapy Based on Gene Production (K Units) by Region (2019-2024)
Table 44. Global Advanced Therapy Based on Gene Revenue (US$ Million) by Region (2019-2024)
Table 45. Global Advanced Therapy Based on Gene Revenue Market Share by Region (2019-2024)
Table 46. Global Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 47. North America Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. Europe Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 49. Japan Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 50. China Advanced Therapy Based on Gene Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 51. Biogen Advanced Therapy Based on Gene Basic Information
Table 52. Biogen Advanced Therapy Based on Gene Product Overview
Table 53. Biogen Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 54. Biogen Business Overview
Table 55. Biogen Advanced Therapy Based on Gene SWOT Analysis
Table 56. Biogen Recent Developments
Table 57. Novartis Advanced Therapy Based on Gene Basic Information
Table 58. Novartis Advanced Therapy Based on Gene Product Overview
Table 59. Novartis Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Novartis Business Overview
Table 61. Novartis Advanced Therapy Based on Gene SWOT Analysis
Table 62. Novartis Recent Developments
Table 63. Gilead Sciences Advanced Therapy Based on Gene Basic Information
Table 64. Gilead Sciences Advanced Therapy Based on Gene Product Overview
Table 65. Gilead Sciences Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 66. Gilead Sciences Advanced Therapy Based on Gene SWOT Analysis
Table 67. Gilead Sciences Business Overview
Table 68. Gilead Sciences Recent Developments
Table 69. Sarepta Therapeutics Advanced Therapy Based on Gene Basic Information
Table 70. Sarepta Therapeutics Advanced Therapy Based on Gene Product Overview
Table 71. Sarepta Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 72. Sarepta Therapeutics Business Overview
Table 73. Sarepta Therapeutics Recent Developments
Table 74. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Basic Information
Table 75. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Product Overview
Table 76. Alnylam Pharmaceuticals Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 77. Alnylam Pharmaceuticals Business Overview
Table 78. Alnylam Pharmaceuticals Recent Developments
Table 79. Amgen Advanced Therapy Based on Gene Basic Information
Table 80. Amgen Advanced Therapy Based on Gene Product Overview
Table 81. Amgen Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 82. Amgen Business Overview
Table 83. Amgen Recent Developments
Table 84. Spark Therapeutics Advanced Therapy Based on Gene Basic Information
Table 85. Spark Therapeutics Advanced Therapy Based on Gene Product Overview
Table 86. Spark Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. Spark Therapeutics Business Overview
Table 88. Spark Therapeutics Recent Developments
Table 89. Akcea Therapeutics Advanced Therapy Based on Gene Basic Information
Table 90. Akcea Therapeutics Advanced Therapy Based on Gene Product Overview
Table 91. Akcea Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Akcea Therapeutics Business Overview
Table 93. Akcea Therapeutics Recent Developments
Table 94. Sunway Biotech Advanced Therapy Based on Gene Basic Information
Table 95. Sunway Biotech Advanced Therapy Based on Gene Product Overview
Table 96. Sunway Biotech Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. Sunway Biotech Business Overview
Table 98. Sunway Biotech Recent Developments
Table 99. SIBIONO Advanced Therapy Based on Gene Basic Information
Table 100. SIBIONO Advanced Therapy Based on Gene Product Overview
Table 101. SIBIONO Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. SIBIONO Business Overview
Table 103. SIBIONO Recent Developments
Table 104. AnGes Advanced Therapy Based on Gene Basic Information
Table 105. AnGes Advanced Therapy Based on Gene Product Overview
Table 106. AnGes Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. AnGes Business Overview
Table 108. AnGes Recent Developments
Table 109. Orchard Therapeutics Advanced Therapy Based on Gene Basic Information
Table 110. Orchard Therapeutics Advanced Therapy Based on Gene Product Overview
Table 111. Orchard Therapeutics Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Orchard Therapeutics Business Overview
Table 113. Orchard Therapeutics Recent Developments
Table 114. Human Stem Cells Institute Advanced Therapy Based on Gene Basic Information
Table 115. Human Stem Cells Institute Advanced Therapy Based on Gene Product Overview
Table 116. Human Stem Cells Institute Advanced Therapy Based on Gene Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Human Stem Cells Institute Business Overview
Table 118. Human Stem Cells Institute Recent Developments
Table 119. Global Advanced Therapy Based on Gene Sales Forecast by Region (2025-2032) & (K Units)
Table 120. Global Advanced Therapy Based on Gene Market Size Forecast by Region (2025-2032) & (M USD)
Table 121. North America Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 122. North America Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 123. Europe Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 124. Europe Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 125. Asia Pacific Advanced Therapy Based on Gene Sales Forecast by Region (2025-2032) & (K Units)
Table 126. Asia Pacific Advanced Therapy Based on Gene Market Size Forecast by Region (2025-2032) & (M USD)
Table 127. South America Advanced Therapy Based on Gene Sales Forecast by Country (2025-2032) & (K Units)
Table 128. South America Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 129. Middle East and Africa Advanced Therapy Based on Gene Consumption Forecast by Country (2025-2032) & (Units)
Table 130. Middle East and Africa Advanced Therapy Based on Gene Market Size Forecast by Country (2025-2032) & (M USD)
Table 131. Global Advanced Therapy Based on Gene Sales Forecast by Type (2025-2032) & (K Units)
Table 132. Global Advanced Therapy Based on Gene Market Size Forecast by Type (2025-2032) & (M USD)
Table 133. Global Advanced Therapy Based on Gene Price Forecast by Type (2025-2032) & (USD/Unit)
Table 134. Global Advanced Therapy Based on Gene Sales (K Units) Forecast by Application (2025-2032)
Table 135. Global Advanced Therapy Based on Gene Market Size Forecast by Application (2025-2032) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Advanced Therapy Based on Gene
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Advanced Therapy Based on Gene Market Size (M USD), 2019-2032
Figure 5. Global Advanced Therapy Based on Gene Market Size (M USD) (2019-2032)
Figure 6. Global Advanced Therapy Based on Gene Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Advanced Therapy Based on Gene Market Size by Country (M USD)
Figure 11. Advanced Therapy Based on Gene Sales Share by Manufacturers in 2023
Figure 12. Global Advanced Therapy Based on Gene Revenue Share by Manufacturers in 2023
Figure 13. Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Advanced Therapy Based on Gene Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Advanced Therapy Based on Gene Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Advanced Therapy Based on Gene Market Share by Type
Figure 18. Sales Market Share of Advanced Therapy Based on Gene by Type (2019-2024)
Figure 19. Sales Market Share of Advanced Therapy Based on Gene by Type in 2023
Figure 20. Market Size Share of Advanced Therapy Based on Gene by Type (2019-2024)
Figure 21. Market Size Market Share of Advanced Therapy Based on Gene by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Advanced Therapy Based on Gene Market Share by Application
Figure 24. Global Advanced Therapy Based on Gene Sales Market Share by Application (2019-2024)
Figure 25. Global Advanced Therapy Based on Gene Sales Market Share by Application in 2023
Figure 26. Global Advanced Therapy Based on Gene Market Share by Application (2019-2024)
Figure 27. Global Advanced Therapy Based on Gene Market Share by Application in 2023
Figure 28. Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
Figure 29. Global Advanced Therapy Based on Gene Sales Market Share by Region (2019-2024)
Figure 30. North America Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 32. U.S. Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Advanced Therapy Based on Gene Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Advanced Therapy Based on Gene Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 37. Germany Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Advanced Therapy Based on Gene Sales Market Share by Region in 2023
Figure 44. China Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 50. South America Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 51. Brazil Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Advanced Therapy Based on Gene Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Advanced Therapy Based on Gene Production Market Share by Region (2019-2024)
Figure 62. North America Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 65. China Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Advanced Therapy Based on Gene Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Advanced Therapy Based on Gene Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Advanced Therapy Based on Gene Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Advanced Therapy Based on Gene Market Share Forecast by Type (2025-2032)
Figure 70. Global Advanced Therapy Based on Gene Sales Forecast by Application (2025-2032)
Figure 71. Global Advanced Therapy Based on Gene Market Share Forecast by Application (2025-2032)
Figure 1. Product Picture of Advanced Therapy Based on Gene
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Advanced Therapy Based on Gene Market Size (M USD), 2019-2032
Figure 5. Global Advanced Therapy Based on Gene Market Size (M USD) (2019-2032)
Figure 6. Global Advanced Therapy Based on Gene Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Advanced Therapy Based on Gene Market Size by Country (M USD)
Figure 11. Advanced Therapy Based on Gene Sales Share by Manufacturers in 2023
Figure 12. Global Advanced Therapy Based on Gene Revenue Share by Manufacturers in 2023
Figure 13. Advanced Therapy Based on Gene Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Advanced Therapy Based on Gene Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Advanced Therapy Based on Gene Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Advanced Therapy Based on Gene Market Share by Type
Figure 18. Sales Market Share of Advanced Therapy Based on Gene by Type (2019-2024)
Figure 19. Sales Market Share of Advanced Therapy Based on Gene by Type in 2023
Figure 20. Market Size Share of Advanced Therapy Based on Gene by Type (2019-2024)
Figure 21. Market Size Market Share of Advanced Therapy Based on Gene by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Advanced Therapy Based on Gene Market Share by Application
Figure 24. Global Advanced Therapy Based on Gene Sales Market Share by Application (2019-2024)
Figure 25. Global Advanced Therapy Based on Gene Sales Market Share by Application in 2023
Figure 26. Global Advanced Therapy Based on Gene Market Share by Application (2019-2024)
Figure 27. Global Advanced Therapy Based on Gene Market Share by Application in 2023
Figure 28. Global Advanced Therapy Based on Gene Sales Growth Rate by Application (2019-2024)
Figure 29. Global Advanced Therapy Based on Gene Sales Market Share by Region (2019-2024)
Figure 30. North America Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 32. U.S. Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Advanced Therapy Based on Gene Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Advanced Therapy Based on Gene Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 37. Germany Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Advanced Therapy Based on Gene Sales Market Share by Region in 2023
Figure 44. China Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 50. South America Advanced Therapy Based on Gene Sales Market Share by Country in 2023
Figure 51. Brazil Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Advanced Therapy Based on Gene Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Advanced Therapy Based on Gene Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Advanced Therapy Based on Gene Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Advanced Therapy Based on Gene Production Market Share by Region (2019-2024)
Figure 62. North America Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 63. Europe Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 64. Japan Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 65. China Advanced Therapy Based on Gene Production (K Units) Growth Rate (2019-2024)
Figure 66. Global Advanced Therapy Based on Gene Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Advanced Therapy Based on Gene Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Advanced Therapy Based on Gene Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Advanced Therapy Based on Gene Market Share Forecast by Type (2025-2032)
Figure 70. Global Advanced Therapy Based on Gene Sales Forecast by Application (2025-2032)
Figure 71. Global Advanced Therapy Based on Gene Market Share Forecast by Application (2025-2032)
